$1.56
-0.07 (-4.29%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,953.8% upside
Low Target
$22.50
Average Target
$32.04
High Target
$35.39
Current Price
$1.56
Current
$1.56
$1.56
Target
$32.04
$32.04
$22.50
$32.04 avg
$35.39
Scenario Analysis
Bear Case
$22.50
1,342.3%
Low target
Base Case
$32.04
+1,953.8%
Avg target
Bull Case
$35.39
+2,168.6%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$16.00
-90.3% from high
52-Week Low
$1.40
+11.4% from low
Target vs 52W High
$32.04
+100.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |